✦ LIBER ✦

The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: The ASSENT PLUS study

✍ Scribed by Lars Wallentin; B. Lindahl; M. Dellborg; T. Nilsson; K. Pehrsson; E. Swahn

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimizing adjunctive antithrombotic the

✍ David Brieger 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

Low-molecular-weight heparin (enoxaparin

✍ P. ZEZOS; G. PAPAIOANNOU; N. NIKOLAIDIS; K. PATSIAOURA; A. PAPAGEORGIOU; T. VASS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

AS-66: Low-Molecular-Weight Heparin vers

✍ Seung Woon Rha; Kang Yin Chen; Yong Jian Li; Kanhaiya Lal Poddar; Zhe Jin; Yoshi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 33 KB

AS-251: Low-Molecular-Weight Heparin ver

✍ Seung Woon Rha; Kang Yin Chen; Yong Jian Li; Kanhaiya Lal Poddar; Zhe Jin; Yoshi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Efficacy and safety of tenecteplase in c

✍ L. Wallentin; P. Goldstein; P.W. Armstrong 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Role of low-molecular-weight heparins in

✍ E.Scott Monrad 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 177 KB